• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

类风湿关节炎的缓解。

Remission in rheumatoid arthritis.

机构信息

Division of Rheumatology, University of California Los Angeles, Veterans Association Greater Los Angeles Health System, Los Angeles, CA, USA.

出版信息

Curr Rheumatol Rep. 2010 Oct;12(5):355-62. doi: 10.1007/s11926-010-0121-2.

DOI:10.1007/s11926-010-0121-2
PMID:20697983
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2927687/
Abstract

With advancing therapeutic options, achieving a state of remission has become the treatment goal in rheumatoid arthritis. Agreeing on what constitutes remission and what measures should be used to assess disease activity has remained a challenge. Multiple remission criteria have been devised and modified, all with different strengths and limitations. A consensus definition of remission will need to be achieved if we are to be able to evaluate outcomes of clinical trials and establish treatment targets for practice. Remission defined as the complete absence of disease currently may not be a realistic therapeutic goal.

摘要

随着治疗选择的不断进步,在类风湿关节炎中达到缓解状态已成为治疗目标。对于什么是缓解以及应该使用哪些措施来评估疾病活动,仍然存在挑战。已经设计并修改了多种缓解标准,它们都具有不同的优缺点。如果我们要能够评估临床试验的结果并为实践确定治疗目标,就需要达成缓解的共识定义。目前,将疾病完全消除定义为缓解可能不是一个现实的治疗目标。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a094/2927687/f6d7e7f44d76/11926_2010_121_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a094/2927687/f6d7e7f44d76/11926_2010_121_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a094/2927687/f6d7e7f44d76/11926_2010_121_Fig1_HTML.jpg

相似文献

1
Remission in rheumatoid arthritis.类风湿关节炎的缓解。
Curr Rheumatol Rep. 2010 Oct;12(5):355-62. doi: 10.1007/s11926-010-0121-2.
2
Progress toward the development of a new definition of remission in rheumatoid arthritis.类风湿关节炎缓解新定义的制定进展
Bull NYU Hosp Jt Dis. 2010;68(2):140-2.
3
Patient perspective on remission in rheumatoid arthritis.患者对类风湿关节炎缓解的看法。
J Rheumatol. 2011 Aug;38(8):1735-8. doi: 10.3899/jrheum.110394.
4
Should modern imaging be part of remission criteria in rheumatoid arthritis?现代影像学检查是否应成为类风湿关节炎缓解标准的一部分?
Best Pract Res Clin Rheumatol. 2012 Dec;26(6):767-85. doi: 10.1016/j.berh.2012.10.004.
5
Methods used to assess remission and low disease activity in rheumatoid arthritis.用于评估类风湿关节炎缓解和低疾病活动度的方法。
Autoimmun Rev. 2010 Jan;9(3):161-4. doi: 10.1016/j.autrev.2009.07.001. Epub 2009 Jul 19.
6
Implementation of a treat-to-target strategy in very early rheumatoid arthritis: results of the Dutch Rheumatoid Arthritis Monitoring remission induction cohort study.在极早期类风湿关节炎中实施达标治疗策略:荷兰类风湿关节炎监测缓解诱导队列研究结果
Arthritis Rheum. 2011 Oct;63(10):2865-72. doi: 10.1002/art.30494.
7
Patient-reported outcomes as assessment tools and predictors of long-term prognosis: a 7-year follow-up study of patients with rheumatoid arthritis.患者报告结局作为评估工具和长期预后的预测指标:类风湿关节炎患者的7年随访研究
Int J Rheum Dis. 2017 Sep;20(9):1193-1200. doi: 10.1111/1756-185X.12789. Epub 2015 Nov 6.
8
Monitoring rheumatoid arthritis.监测类风湿关节炎。
Curr Opin Rheumatol. 2011 May;23(3):252-8. doi: 10.1097/BOR.0b013e328345743a.
9
What should be our treatment goal in rheumatoid arthritis today?如今,我们在类风湿关节炎中的治疗目标应该是什么?
Clin Exp Rheumatol. 2006 Nov-Dec;24(6 Suppl 43):S-7-13.
10
Defining remission in rheumatoid arthritis: results of an initial American College of Rheumatology/European League Against Rheumatism consensus conference.类风湿关节炎缓解的定义:美国风湿病学会/欧洲抗风湿病联盟首次共识会议的结果
Arthritis Rheum. 2009 May 15;61(5):704-10. doi: 10.1002/art.24392.

引用本文的文献

1
Does remission in rheumatoid arthritis bring kinesiophobia, quality of life, fatigue, and physical activity closer to normal?类风湿关节炎的缓解能否使运动恐惧、生活质量、疲劳及身体活动更接近正常水平?
Arch Rheumatol. 2022 Oct 19;37(4):603-612. doi: 10.46497/ArchRheumatol.2022.9552. eCollection 2022 Dec.
2
Pain, sleep and emotional well-being explain the lack of agreement between physician- and patient-perceived remission in early rheumatoid arthritis.疼痛、睡眠和情绪健康解释了早期类风湿关节炎中医生与患者所感知的缓解之间缺乏一致性的原因。
BMC Rheumatol. 2018 Jun 26;2:16. doi: 10.1186/s41927-018-0024-9. eCollection 2018.
3

本文引用的文献

1
Remission in early rheumatoid arthritis.早期类风湿关节炎的缓解。
J Rheumatol. 2010 Jul;37(7):1444-53. doi: 10.3899/jrheum.091131. Epub 2010 Jun 1.
2
Can disease-modifying anti-rheumatic drugs be discontinued in long-standing rheumatoid arthritis? A 15-year follow-up.疾病修正抗风湿药物能否在长期类风湿关节炎中停用?一项 15 年随访研究。
Scand J Rheumatol. 2010;39(1):12-8. doi: 10.3109/03009740903042394.
3
Rheumatoid arthritis: can we achieve true drug-free remission in patients with RA?类风湿关节炎:我们能否使类风湿关节炎患者达到真正的药物缓解?
MR and ultrasound of the hands and wrists in rheumatoid arthritis. Part II. Added clinical value.
类风湿关节炎手部和腕部的磁共振成像及超声检查。第二部分。额外的临床价值。
Skeletal Radiol. 2019 Jun;48(6):837-857. doi: 10.1007/s00256-019-03180-6. Epub 2019 Feb 26.
4
Achieving comprehensive disease control in patients with early and established rheumatoid arthritis treated with adalimumab plus methotrexate versus methotrexate alone.在早期和确诊的类风湿关节炎患者中,与单用甲氨蝶呤相比,使用阿达木单抗联合甲氨蝶呤实现全面疾病控制的情况。
RMD Open. 2017 Sep 26;3(2):e000445. doi: 10.1136/rmdopen-2017-000445. eCollection 2017.
5
Biologic Disease-Modifying Antirheumatic Drugs in a National, Privately Insured Population: Utilization, Expenditures, and Price Trends.全国私人保险人群中生物性改善病情抗风湿药的使用情况、支出及价格趋势
Am Health Drug Benefits. 2017 Feb;10(1):27-36.
6
Effect of Bizhongxiao decoction and its dismantled formulae on IL-1 and TNF levels in collagen-induced arthritis in rat synovial joints.痹肿消汤及其拆方对胶原诱导性关节炎大鼠滑膜关节中白细胞介素-1和肿瘤坏死因子水平的影响。
Theor Biol Med Model. 2012 Nov 20;9:47. doi: 10.1186/1742-4682-9-47.
7
An association study of disease activity score components and patient satisfaction with overall health for early RA patients on non-biologic DMARD therapy.早期接受非生物性 DMARD 治疗的类风湿关节炎患者的疾病活动评分成分与总体健康满意度的关联研究。
Rheumatol Int. 2012 Sep;32(9):2725-9. doi: 10.1007/s00296-011-2037-1. Epub 2011 Jul 30.
Nat Rev Rheumatol. 2010 Feb;6(2):68-70. doi: 10.1038/nrrheum.2009.253.
4
Does clinical remission lead to normalization of EQ-5D in patients with rheumatoid arthritis and is selection of remission criteria important?临床缓解是否能使类风湿关节炎患者的 EQ-5D 正常化,缓解标准的选择是否重要?
J Rheumatol. 2010 Feb;37(2):285-90. doi: 10.3899/jrheum.090898. Epub 2010 Jan 15.
5
Forefoot disease activity in rheumatoid arthritis patients in remission: results of a cohort study.缓解期类风湿关节炎患者的前足疾病活动:一项队列研究的结果。
Arthritis Res Ther. 2010;12(1):R3. doi: 10.1186/ar2901. Epub 2010 Jan 7.
6
Superiority of SDAI over DAS-28 in assessment of remission in rheumatoid arthritis patients using power Doppler ultrasonography as a gold standard.SDAI 在评估使用功率多普勒超声作为金标准的类风湿关节炎患者缓解方面优于 DAS-28。
Rheumatology (Oxford). 2010 Apr;49(4):683-90. doi: 10.1093/rheumatology/kep442. Epub 2010 Jan 4.
7
Prevalence of and predictive factors for sustained disease-modifying antirheumatic drug-free remission in rheumatoid arthritis: results from two large early arthritis cohorts.类风湿关节炎中持续停用改善病情抗风湿药缓解的患病率及预测因素:来自两个大型早期关节炎队列的结果
Arthritis Rheum. 2009 Aug;60(8):2262-71. doi: 10.1002/art.24661.
8
Methods used to assess remission and low disease activity in rheumatoid arthritis.用于评估类风湿关节炎缓解和低疾病活动度的方法。
Autoimmun Rev. 2010 Jan;9(3):161-4. doi: 10.1016/j.autrev.2009.07.001. Epub 2009 Jul 19.
9
Ultrasonographic evaluation of joint involvement in early rheumatoid arthritis in clinical remission: power Doppler signal predicts short-term relapse.临床缓解期早期类风湿关节炎关节受累的超声评估:能量多普勒信号可预测短期复发。
Rheumatology (Oxford). 2009 Sep;48(9):1092-7. doi: 10.1093/rheumatology/kep171. Epub 2009 Jun 26.
10
Accuracy of Wallace criteria for clinical remission in juvenile idiopathic arthritis: a cohort study of 761 consecutive cases.青少年特发性关节炎临床缓解的华莱士标准的准确性:对761例连续病例的队列研究
J Rheumatol. 2009 Jul;36(7):1532-5. doi: 10.3899/jrheum.080434. Epub 2009 Jun 1.